Advertisement

Topics

PCAS-NANOSYN, LLC Company Profile

16:24 EST 21st November 2017 | BioPortfolio

PCAS (www.pcas.com) is a listed group on the Paris Stockmarket. A leading Fine Chemical company, PCAS operates eight chemical plants in Europe and North America and offers world-class services related to the process development and manufacturing of multi-step, complex organic chemicals from kilolab to multi-ton scale. PCAS provides services for the pharmaceutical, flavor and fragrance, cosmetic, and industrial market sectors.


News Articles [6 Associated News Articles listed on BioPortfolio]

Global and Asia Lubricant Additives Market Status and Future Forecast 20132023 [Report Updated: 24102017] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global Bioresorbable Medical Material Market Data Survey Report 2025 [Report Updated: 22102017] Prices from USD $1500

SummaryThe bioresorbable medical material in this report contains polylactic acid PLA, polyglycolic acid PGA, polysaccharides, polycaprolactone PCL and PLGA.The global Bioresorbable Medical Material m...

Global Bioresorbable Medical Material Market Research Report 20112023 [Report Updated: 13102017] Prices from USD $2150

SummaryThe bioresorbable medical material in this report contains polylactic acid PLA, polyglycolic acid PGA, polysaccharides, polycaprolactone PCL and PLGA.The global Bioresorbable Medical Material m...

Global Lubricant Additives Market Data Survey Report 2025 [Report Updated: 19082017] Prices from USD $1500

SummaryLubricant Additives refer to the additives Chemicalproduct used in the lubricant. including: Antioxidants, Antiwear Agents, Corrosion Inhibitors, Detergents, Dispersants, Extreme Pressure Addit...

Global PLGA Market Research 2011 2022 [Report Updated: 14062017] Prices from USD $2060

SummaryPLGA poly lacticcoglycolic acid is a unique base polymer for controlled release of drugs and medical implant materials. It is both biodegradable and biocompatible, and since both monomers occur...

Global PLGA Market Analysis 20112017 and Forecast 20182023 [Report Updated: 08092017] Prices from USD $2980

SnapshotPLGA poly lacticcoglycolic acid is a unique base polymer for controlled release of drugs and medical implant materials. It is both biodegradable and biocompatible, and since both monomers occu...

Drugs and Medications [0 Results]

None

PubMed Articles [6 Associated PubMed Articles listed on BioPortfolio]

Anticancer Ru(η(6)-p-cymene) complexes of 2-pyridinecarbothioamides: A structure-activity relationship study.

Ru(II) and Os(II) complexes of 2-pyridinecarbothioamide ligands were introduced as orally administrable anticancer agents (S.M. Meier, M. Hanif, Z. Adhireksan, V. Pichler, M. Novak, E. Jirkovsky, M.A....

Examining factors associated with elevated Lie Scale responding on the Child Abuse Potential Inventory.

Child maltreatment remains a serious public health issue in the United States. Therefore, it is important to engage in quality control of the assessment, prevention, and treatment services for familie...

Extracellular Matrix Cartilage Allograft and Particulate Cartilage Allograft for Osteochondral Lesions of the Knee and Ankle Joints: A Systematic Review.

Extracellular matrix cartilage allografts (EMCAs) and particulate cartilage allografts (PCAs) are relatively new biologics that may improve the quality of cartilage regeneration after bone marrow stim...

Intranasal post-cardiac arrest treatment with orexin-A facilitates arousal from coma and ameliorates neuroinflammation.

Cardiac arrest (CA) entails significant risks of coma resulting in poor neurological and behavioral outcomes after resuscitation. Significant subsequent morbidity and mortality in post-CA patients are...

Sex differences in the role of phospholipase A2 -dependent arachidonic acid pathway in the perivascular adipose tissue function in pigs.

Previous studies have demonstrated that perivascular adipose tissue (PVAT) causes vasoconstriction. In this present study, we determined the role of cyclooxygenase-derived prostanoids in this contract...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

Transitions Between Clinical Circulatory States After Out-of-hospital Cardiac Arrest

Extensive research exists for cardio-pulmonary resuscitation (CPR) and the chance of successful return of spontaneous circulation (ROSC) is improved. Unfortunately, the overall prognosis a...

Treatment of Postoperative Pain After Total Knee Arthroplasy Using Intravenous Lidocaine Infusion

Total knee replacement is often associated with severe postoperative pain, especially in the first 24 hours. Patient controlled analgesia (PCA) and continuous femoral block with PCA are c...

Continuous NMB in PCAS

The main purpose of this study is to test the hypothesis that continuous NMB could improve outcome in cardiac arrest patients treated with therapeutic hypothermia.

Inhaled Nitric Oxide After Out-of-Hospital Cardiac Arrest

Phase II double blind (participants and investigator) placebo controlled randomized (1:1) clinical trial of inhaled nitric oxide (iNO) 20 ppm administered over 12h beginning as soon as pos...

Endothelial Dysfunction in Resuscitated Cardiac Arrest

Objective: Safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac-arr...

Companies [3 Associated Companies listed on BioPortfolio]

PCAS-NANOSYN, LLC

PCAS (www.pcas.com) is a listed group on the Paris Stockmarket. A leading Fine Chemical company, PCAS operates eight chemical plants in Europe and North America and offers world-class services related...

PCAS Finland Oy

PCAS Finland Oy has produced APIs since 1960, and it was the first company to produce active pharmaceutical ingredients in commercial quantities in Finland. Until June 2001, PCAS Finland Oy was an int...

Nanosyn

Nanosyn is a privately held chemistry-based enterprise founded in 1998 by a group of industry experts specializing in the design, synthesis, and analysis of small molecule organic compounds for the ph...

More Information about "PCAS-NANOSYN, LLC" on BioPortfolio

We have published hundreds of PCAS-NANOSYN, LLC news stories on BioPortfolio along with dozens of PCAS-NANOSYN, LLC Clinical Trials and PubMed Articles about PCAS-NANOSYN, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of PCAS-NANOSYN, LLC Companies in our database. You can also find out about relevant PCAS-NANOSYN, LLC Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record